Media Summary: In this joint discussion session, Chris Garabedian from Xontogeny, Madan Jagasia from Iovance Biotherapeutics, and Duncan ... Sponsored by Precision for Medicine Chair: Deborah Phippard, Ph.D., Chief Scientific Officer, Precision for Medicine Speakers: ... In 2023, the Food and Drug Administration (FDA) approved the first gene
Emerging Technologies Cellular Therapy Today - Detailed Analysis & Overview
In this joint discussion session, Chris Garabedian from Xontogeny, Madan Jagasia from Iovance Biotherapeutics, and Duncan ... Sponsored by Precision for Medicine Chair: Deborah Phippard, Ph.D., Chief Scientific Officer, Precision for Medicine Speakers: ... In 2023, the Food and Drug Administration (FDA) approved the first gene This symposium highlighted progress in the development of disruptive scientific approaches and game-changing Advances in cancer immunotherapy continue to reshape how scientists approach
